医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
BRVE · Braveheart Bio, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Braveheart Bio, Inc.（BRVE）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 $122.6M、卖出 —；高管董事有效买入 $3.1M、有效卖出 —。最近申报 2026-08-11。
买入 Bought$122.6M
卖出 Sold—
有效买入 Effective bought$3.1M
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-08-07 | AH Bio Fund IV, L.P. 10% Owner | 买入 Buy | 1,100,000 | $18.00 | $19.8M | SEC |
| 2026-08-07 | ORBIMED ADVISORS LLC 10% Owner, Director | 买入 Buy | 1,940,000 | $18.00 | $34.9M | SEC |
| 2026-08-07 | Anderson Michele A. Chief Development Officer | 买入 Buy · 有效 | 1,111 | $18.00 | $20K | SEC |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. 10% Owner | 买入 Buy | 3,600,000 | $18.00 | $64.8M | SEC |
| 2026-08-07 | Lubner David Charles Director | 买入 Buy · 有效 | 55,555 | $18.00 | $1000K | SEC |
| 2026-08-07 | Murdoch Travis CEO and President, Director | 买入 Buy · 有效 | 83,333 | $18.00 | $1.5M | SEC |
| 2026-08-07 | Malek David I Director | 买入 Buy · 有效 | 4,166 | $18.00 | $75K | SEC |
| 2026-08-07 | Rickey James Paul Chief Financial Officer | 买入 Buy · 有效 | 27,777 | $18.00 | $500K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
内部人 Insiders
AH Bio Fund IV, L.P.、ORBIMED ADVISORS LLC、Anderson Michele A.、Forbion Growth Opportunities Fund III Cooperatief U.A.、Lubner David Charles、Murdoch Travis、Malek David I、Rickey James Paul